Companies
Alexandria Real Estate Equities
S&P 500Real Estate· USA

ARE

Status-Quo-Player

Alexandria Real Estate Equities

$43.75

+2.68%

Open $42.26·Prev $42.61

as of 13 Apr

STATUS-QUO-PLAYER

Power Core

life science ecosystems, where tenant density creates self-reinforcing demand that compounds independently of macroeconomic cycles.

Published1 Apr 2026
UniverseS&P 500
SectorReal Estate

Direction of Movement

Lateral Consolidation With Cyclical Recovery Potential

ROC 200

-40.5%

Referenced in 22 other analyses

mOS zones are proprietary L17X overlays and do not constitute trading signals or investment advice.

Company Profile

Alexandria Real Estate Equities, Inc. is an S&P 500 company and a leading real estate investment trust (REIT) focused exclusively on the life science sector. It owns, operates, and develops collaborative Megacampus ecosystems designed to foster innovation and productivity for life science tenants. These properties are strategically located in premier innovation clusters across North America, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. The company specializes in high-quality Class A/A+ properties that support research, development, and production activities for biotechnology, pharmaceutical, and medical technology firms. Alexandria Real Estate Equities, Inc. also provides strategic venture capital to promising life science companies, enhancing its role in the ecosystem. Founded in 1994 and headquartered in Pasadena, California, it maintains an investment-grade balance sheet and emphasizes long-term stability through diverse, high-occupancy tenant relationships and mission-driven real estate solutions tailored to the dynamic needs of the life science industry.

Sector

Real Estate

Industry

REIT - Office

CEO

Mr. Peter M. Moglia

Employees

552

Country

United States

This page is for informational purposes only and does not constitute investment advice. L17X Research is an independent research service.